In the rapidly evolving landscape of telehealth, two names stand out: HIMS and Ro. Both companies are pioneering direct-to-consumer healthcare solutions, but they approach their missions with distinct strategies that reflect their unique visions for the future.
HIMS & Hers Health has carved a niche as a leader in remote medical services since its inception in 2017. Founded by Andrew Dudum, HIMS emerged from an acute awareness of unmet needs in men's health—specifically issues like hair loss and erectile dysfunction that many men find difficult to discuss openly. By offering personalized treatment plans through a subscription model, HIMS has amassed over 2.4 million subscribers by Q2 2025, boasting impressive retention rates above 85%.
The company’s core offerings span sexual health, dermatology for both genders, mental health support, and weight management solutions—all delivered discreetly online. This comprehensive approach not only caters to immediate consumer needs but also fosters long-term relationships with users who appreciate privacy and convenience.
On the other hand, Ro is making waves with its focused strategy on specific health concerns such as hair loss and skin care while expanding into broader areas like sexual wellness. Although it holds about 15% market share compared to HIMS's dominant position at approximately 47%, Ro's recent growth trajectory is noteworthy; traffic surged by nearly 90% year-over-year as of March 2025.
Ro differentiates itself through high marketing efficiency—43% organic traffic—and competitive pricing aimed at price-sensitive consumers seeking affordable healthcare options without compromising quality or accessibility.
While both companies leverage technology to enhance user experience—like HIMS’s AI-driven MedMatch system which personalizes treatment recommendations based on extensive data analysis—their operational models diverge significantly when it comes to service delivery methods.
HIMS operates an integrated ecosystem where diagnosis leads directly into prescription fulfillment via owned pharmacies capable of producing customized medications tailored specifically for individual patients’ needs—a feature that gives them significant control over product quality and customer satisfaction.
Conversely, Ro recently merged with Thirty Madison to streamline operations further towards subscription-based services targeting younger demographics (18-34 years old), thereby increasing engagement among millennials who value affordability alongside efficacy in healthcare solutions.
Despite these differences in focus and execution style between HIMS and Ro—which include varied approaches toward handling sensitive topics within male-oriented markets—the competition remains fierce as each strives not just for market dominance but also for innovation that meets changing consumer expectations amidst rising demand across telemedicine sectors globally.